Cargando…
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
BACKGROUND: Despite high contagiousness and rapid spread, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to heterogeneous outcomes across affected nations. Within Europe (EU), the United Kingdom (UK) is the most severely affected country, with a death toll in excess of 100,000...
Ejemplares similares
-
318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients
por: Pinato, D.J., et al.
Publicado: (2020) -
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
por: Dettorre, Gino M, et al.
Publicado: (2021) -
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
por: Pinato, David J, et al.
Publicado: (2021) -
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
por: Garrigós, Laia, et al.
Publicado: (2021) -
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
por: Cortellini, Alessio, et al.
Publicado: (2022)